Quality parameters for the medicinal plant Drosera rotundifolia L.: A new approach with established techniques.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300436
- By:
- Publication type:
- Article
Works matching IS 03656233 AND DT 2024 AND VI 357 AND IP 1
Results: 16
1
2
Molecular insights into the anti‐inflammatory activity of fermented pineapple juice using multimodal computational studies.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300422
- By:
- Publication type:
- Article
3
Editorial Board: Arch Pharm (1/2024).
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202470024
- Publication type:
- Article
4
Cover Picture: Arch Pharm (1/2024).
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202470023
- Publication type:
- Article
5
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300494
- By:
- Publication type:
- Article
6
Discovery of novel benzimidazole acyclic C‐nucleoside DNA intercalators halting breast cancer growth.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300454
- By:
- Publication type:
- Article
7
Identification of 3‐(5‐cyano‐6‐oxo‐pyridin‐2‐yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300449
- By:
- Publication type:
- Article
8
Exploration of 1,2,3‐triazolo fused triterpenoids as inhibitors of human coronavirus 229E targeting the viral nsp15 protein.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300442
- By:
- Publication type:
- Article
9
Chemical substances and their activities in sea cucumber Apostichopus japonicus: A review.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300427
- By:
- Publication type:
- Article
10
Evaluation of in vitro SARS‐CoV‐2 inactivation by a new quaternary ammonium compound: Bromiphen bromide.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300424
- By:
- Publication type:
- Article
11
Synthesis and biological evaluation of novel salicylidene uracils: Cytotoxic activity on human cancer cell lines and inhibitory action on enzymatic activity.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300374
- By:
- Publication type:
- Article
12
New paracetamol hybrids as anticancer and COX‐2 inhibitors: Synthesis, biological evaluation and docking studies.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300340
- By:
- Publication type:
- Article
13
Natural flavonoids as promising 6‐phosphogluconate dehydrogenase inhibitor candidates: In silico and in vitro assessments.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300326
- By:
- Publication type:
- Article
14
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300328
- By:
- Publication type:
- Article
15
Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300301
- By:
- Publication type:
- Article
16
Synthesis and molecular docking simulation of new benzimidazole–thiazole hybrids as cholinesterase inhibitors.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 1, p. 1, doi. 10.1002/ardp.202300201
- By:
- Publication type:
- Article